Short Interest in Gelteq Limited (NASDAQ:GELS) Increases By 2,478.9%

Posted by Micah Haroldson on Jan 28th, 2026

Gelteq Limited (NASDAQ:GELS – Get Free Report) saw a significant growth in short interest in January. As of January 15th, there was short interest totaling 1,003,425 shares, a growth of 2,478.9% from the December 31st total of 38,909 shares. Based on an average daily volume of 5,802,384 shares, the days-to-cover ratio is currently 0.2 days. Currently, 10.6% of the company’s stock are sold short. Currently, 10.6% of the company’s stock are sold short. Based on an average daily volume of 5,802,384 shares, the days-to-cover ratio is currently 0.2 days.

Gelteq Price Performance

Shares of GELS opened at $1.03 on Wednesday. The business’s 50 day moving average price is $0.97 and its 200-day moving average price is $1.24. Gelteq has a 52 week low of $0.67 and a 52 week high of $4.11.

Institutional Investors Weigh In On Gelteq

An institutional investor recently bought a new position in Gelteq stock. Susquehanna International Group LLP purchased a new stake in shares of Gelteq Limited (NASDAQ:GELS – Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 41,550 shares of the company’s stock, valued at approximately $57,000. Susquehanna International Group LLP owned approximately 0.44% of Gelteq at the end of the most recent reporting period.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Gelteq in a report on Monday, December 29th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock presently has an average rating of “Sell”.

Read Our Latest Stock Analysis on GELS

Gelteq Company Profile

(Get Free Report)

Gelteq Inc is a biotechnology company which specializes in the formulation, development and manufacturing of ingestible gel platform designed for nutrient and drug delivery. The Company is focused on advancing and commercializing its delivery solutions within core verticals pharmaceuticals, over-the-counter medications, nutraceuticals, animal medications and sports nutrition. Gelteq Inc is based in NEW YORK.